MedX Health Corp. (Mississauga, ON, Canada), developer of non-invasive low level laser and light therapy for tissue repair and pain relief, says it has received a Notice of Allowance by the U.S. Patent & Trademark Office (USPTO) for its MedX Laser and Light Probe use and method for bone healing, bone growth stimulation and bone cartilage regeneration. The allowed claims cover the use of MedX's laser and light unit and the use of light therapy in various bone and cartilage healing situations such as carpal tunnel syndrome, tendonitis, bone growth and regeneration following a break, rheumatoid arthritis and wound healing.
The light emitted by MedX's probe triggers biological changes within the body, stimulating and accelerating cellular metabolic processes. This increases circulation by formulating new capillaries, and also stimulates collagen protein production, thus accelerating the healing process by helping damaged bone cells and tissue replace themselves more rapidly.
The use of low level lasers and light therapy has been documented as effective in promoting healing of bone, muscle, cartilage, tendon and ligaments. The newly allowed claims will cover The MedX Laser and Light Probe and its use in the treatment of damaged bone and cartilage. The allowance is "another important step toward our entry into the wound healing market, which we expect will take place this year," says Steve Guillen, president and CEO of MedX Health.
MedX Health designs, manufactures, and distributes low level laser and light therapy technology for use in numerous medical settings for rehabilitation, pain relief, and healing of tissue and bone. Last month, the company received FDA Institutional Review Board (IRB) approval to study the effectiveness of laser acupuncture for addiction to nicotine, alcohol and drugs.
The company is expanding its distribution network and marketing program globally through strategic partnerships, while continuing to develop and acquire new dental, rehabilitation and wound care products. In particular, MedX plans to accelerate the development of a new product for wound care. The newest patent allowance for bone growth joins several key existing patents, including "Photobandage," a technology that allows a wound to be bathed in light and is designed to enhance the healing process. The company intends to license its wound care technologies to one or more major wound care companies for further development, marketing and commercialization.
More information:
See MedX Health's website.
